Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity
- 31 August 2005
- journal article
- Published by Elsevier BV in Journal of Dermatological Science
- Vol. 39 (2), 105-112
- https://doi.org/10.1016/j.jdermsci.2005.02.002
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 27 references indexed in Scilit:
- Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamideBlood, 2005
- CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeEuropean Journal of Immunology, 2004
- Regulatory T cells in spontaneous autoimmune encephalomyelitisImmunological Reviews, 2001
- T Cell-Mediated Maintenance of Natural Self-Tolerance: its Breakdown as a Possible Cause of Various Autoimmune DiseasesJournal of Autoimmunity, 1996
- Analysis of Dose Response of Trinitrochlorobenzene Contact Hypersensitivity Induction in Mice: Pretreatment with Cyclophosphamide Reveals an Optimal Sensitizing DoseJournal of Investigative Dermatology, 1990
- Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in nod miceEuropean Journal of Immunology, 1988
- Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumorInternational Journal of Immunopharmacology, 1985
- Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytesThe Journal of Experimental Medicine, 1977
- Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in miceNature, 1976
- Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea PigJournal of Investigative Dermatology, 1967